WALLACE RHEUMATIC DISEASE FOUNDATION

EIN: 455434561 501(c)(3) Medical Research

BEVERLY HILLS, CA

Total Revenue
$188,035
Total Expenses
$127,006
Total Assets
$100,755
Net Assets
$100,755
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2012
Legal Domicile
CA
Principal Officer
DANIEL WALLACE
Phone
7472033377
Tax Period
2025-01-01 to 2025-12-31

WALLACE RHEUMATIC DISEASE FOUNDATION, founded in 2012, is a small nonprofit in the Medical Research sector that reported $188K in total revenue in fiscal year 2025. Revenue surged 28% from the prior year, signaling strong growth momentum. The organization ran a surplus of $61K, a strong 32% operating margin.

Mission

FUNDING CUTTING-EDGE RESEARCH, FELLOWSHIP PROGRAMS AND PATIENT ACCESS TO CARE GRANTS

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $187,995
Program Service Revenue $0
Investment Income $40
Other Revenue $0
TOTAL REVENUE $188,035

Expense Breakdown

Grants Paid $12,200
Salaries & Benefits $30,000
Fundraising Expenses $0
Program Expenses $12,200
Other Expenses $84,806
TOTAL EXPENSES $127,006

Year-over-Year Comparison

2025 2024 Change
Revenue $188,035 $146,836 +0.3%
Expenses $127,006 $221,621 -0.4%
Net Income $61,029 $-74,785 -1.8%
Key Indicators
✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
1
Independent Members
N/A
Employees
N/A
Volunteers
N/A

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
0
$0
Total Directors
1
$30,000
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
DANIEL WALLACE PRESIDENT 1.00
Director
$30,000 $0 $30,000
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $188,035 $127,006 $100,755 $61,029
2024 $146,836 $221,621 $39,726 $-74,785
2020 $257,399 $297,142 $153,617 $-39,743
2019 $253,779 $238,957 $188,258 $14,822
2018 $243,770 $229,524 $173,435 $14,246
Explore More Nonprofits
→Top 100 Nonprofits in California →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare WALLACE RHEUMATIC DISEASE FOUNDATION with other nonprofits in California and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.